Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG82 b&c

被引:63
作者
Kyndi, M. [1 ,2 ]
Sorensen, F. B. [2 ]
Knudsen, H. [3 ]
Overgaard, M. [4 ]
Nielsen, H. M.
Andersen, J. [4 ]
Overgaard, J.
机构
[1] Aarhus Univ Hosp, Arhus Sygehus, Dept Expt Clin Oncol, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ Hosp, Dept Pathol, DK-8000 Aarhus C, Denmark
[3] Herlev Hosp, Dept Pathol, DK-2730 Herlev, Denmark
[4] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus C, Denmark
关键词
D O I
10.1080/02841860701851871
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Introduction. The tissue microarray (TMA) technique comprises the potential of significantly reducing time and tissue spent on slicing and performing immunohistochemical (IHC) stainings of paraffin-embedded tumor tissue. Tissue heterogeneity is an argument against using TMAs, which has been dealt with by increasing the size and number of cores punched from each tumor. No consensus exists on the most optimal size, number, and position of TMA cores in the donor paraffin block and no information exist regarding agreement between TMA cores from two different paraffin blocks from the same tumor or between TMA cores and biochemical analyses. Patients and methods. A central and a peripheral 1mm core and a whole section from each of 54 paraffin blocks from 27 breast cancers included in a one-institution cohort, and a single 1 min central TMA core, from each breast tumor from 1000 patients included in the DBCG82 b&c trials, were IHC stained for ER, PgR and HER2. In addition, ER and PgR were measured in the DBCG82 b&c trials by a biochemical analysis. Statistical analyses included Kappa statistics, Kaplan-Meier survival curves, Log-rank tests, and Cox regression hazards analyses. Results and conclusion. IHC stainings for ER, PgR, and HER2 showed a substantial agreement between a single I mm TMA core and the corresponding whole section, between central and peripheral cores, and between cores from two different paraffin blocks from the same tumor. In addition, a fine agreement was found for ER and PgR between IHC stainings of TMA cores and biochemical analyses. Divergence between IHC and biochemical analyses was predominantly due to the chosen thresholds. IHC staining of one 1mm core from each tumor revealed a significant independent prognostic value of PgR and HER2 on overall survival. In conclusion, IHC stainings for ER, PgR, and HER2 of a single 1mm TMA core seems to be sufficient, as no significant heterogeneity was noticed.
引用
收藏
页码:591 / 599
页数:9
相关论文
共 22 条
[2]
Feasibility of using tissue microarrays for the assessment of HER-2 gene amplification by fluorescence in situ hybridization in breast carcinoma [J].
Bhargava, R ;
Lal, P ;
Chen, BY .
DIAGNOSTIC MOLECULAR PATHOLOGY, 2004, 13 (04) :213-216
[3]
HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS [J].
BLOOM, HJG ;
RICHARDSON, WW .
BRITISH JOURNAL OF CANCER, 1957, 11 (03) :359-&
[4]
Validation of tissue microarray technology in breast carcinoma [J].
Camp, RL ;
Charette, LA ;
Rimm, DL .
LABORATORY INVESTIGATION, 2000, 80 (12) :1943-1949
[5]
Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays [J].
Henriksen, Katrine L. ;
Rasmussen, Birgitte B. ;
Lykkesfeldt, Anne E. ;
Moller, Susanne ;
Ejlertsen, Bent ;
Mouridsen, Henning T. .
JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (04) :397-404
[6]
HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma [J].
Hoang, MP ;
Sahin, AA ;
Ordòñez, NG ;
Sneige, N .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (06) :852-859
[7]
Tissue microarrays for high-throughput molecular profiling of tumor specimens [J].
Kononen, J ;
Bubendorf, L ;
Kallioniemi, A ;
Bärlund, M ;
Schraml, P ;
Leighton, S ;
Torhorst, J ;
Mihatsch, MJ ;
Sauter, G ;
Kallioniemi, OP .
NATURE MEDICINE, 1998, 4 (07) :844-847
[8]
Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: Long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies [J].
Nielsen, HM ;
Overgaard, M ;
Grau, C ;
Jensen, AR ;
Overgaard, J .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (15) :2268-2275
[9]
The prognostic relevance of estimates of proliferative activity in early breast cancer [J].
Offersen, BV ;
Sorensen, FB ;
Knoop, A ;
Overgaard, J .
HISTOPATHOLOGY, 2003, 43 (06) :573-582
[10]
Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen:: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial [J].
Overgaard, M ;
Jensen, MB ;
Overgaard, J ;
Hansen, PS ;
Rose, C ;
Andersson, M ;
Kamby, C ;
Kjær, M ;
Gadeberg, CC ;
Rasmussen, BB ;
Blichert-Toft, M ;
Mouridsen, HT .
LANCET, 1999, 353 (9165) :1641-1648